MONCTON, NB, July 22, 2025 /CNW/ - Today, the Honourable Marjorie Michel, Minister of Health, accompanied by the Honourable Ginette Petitpas Taylor, Member of Parliament...
The comprehensive subscription programme offers OMRON customers in Singapore access to personalised health protection and insights
SINGAPORE, July 22, 2025 /PRNewswire/ -- Global insurtech bolttech...
ATLANTA, July 21, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed Rocket Pharmaceuticals, Inc. (“Rocket Pharmaceuticals” or the “Company”) (NASDAQ: RCKT). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to adequately disclose that Rocket Pharmaceuticals knew Serious Adverse Events (SAEs), including death of participants enrolled in the study, were a risk.